Guggulu: Difference between revisions
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
}} | }} | ||
Commiphora mukul (Hook ex Stock) | [[wikipedia:Commiphora_wightii|Commiphora mukul]] (Hook ex Stock) | ||
{{Infobox | {{Infobox | ||
| Line 31: | Line 31: | ||
}} | }} | ||
'''Guggulu''' (also known as '''Guggul''' or '''Gum Guggulu''') is an | '''Guggulu''' (also known as '''Guggul''' or '''Gum Guggulu''') is an oleo-gum-resin exuded from the trunk of ''Commiphora wightii'' (syn. ''Commiphora mukul''), a flowering plant belonging to the family Burseraceae. Renowned in Ayurvedic medicine for over three millennia, Guggulu is traditionally prescribed for conditions characterized by lipid accumulation, chronic inflammation, metabolic sluggishness, and joint degeneration. In modern phytomedicine, its active steroidal compounds, known as guggulsterones, have been investigated for their hypolipidemic, anti-atherosclerotic, anti-inflammatory, and thyroid-stimulating properties. | ||
==Therapeutic Uses== | ==Therapeutic Uses== | ||
[[File:Guggulu.jpg|thumb|'''Guggulu (''Commiphora mukul'')''']] | |||
Amavata (Rheumatoid arthritis), Kushtha (Obstinate skin diseases), Prameha (Obstinate Urinary disorders including Diabetes mellitus), Vatavyadhi, Granthi (Tumors/warts), Sopha (Inflammation), Gandamala (Goitre), Medoroga (Obesity, and lowers cholesterol)<ref>Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry | Amavata (Rheumatoid arthritis), Kushtha (Obstinate skin diseases), Prameha (Obstinate Urinary disorders including Diabetes mellitus), Vatavyadhi, Granthi (Tumors/warts), Sopha (Inflammation), Gandamala (Goitre), Medoroga (Obesity, and lowers cholesterol)<ref>Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry | ||
of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume I:28</ref> | of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume I:28</ref> | ||
| Line 264: | Line 265: | ||
Mentioned 2 types<ref>Dr. Indradev Tripathi, Raj Nighantu of Pandit Narahari, Chandanadi Varga, Verse no. | Mentioned 2 types<ref>Dr. Indradev Tripathi, Raj Nighantu of Pandit Narahari, Chandanadi Varga, Verse no. | ||
107 Chaukhambha Krishnadas academy, Varanasi;</ref> | 107 Chaukhambha Krishnadas academy, Varanasi;</ref> | ||
1.Gandharaja Guggulu / Kana guggulu | |||
2.Bhumija guggulu | |||
==Prashashta Guggulu (Qualities of Genuine Guggulu)== | ==Prashashta Guggulu (Qualities of Genuine Guggulu)== | ||
| Line 323: | Line 325: | ||
|} | |} | ||
'''Note on Purification (Shodhana):''' Raw Guggulu contains extraneous impurities and toxic fraction constituents that can cause gastric distress or skin allergic responses. Prior to therapeutic use, it undergoes ''Shodhana'' (purification) by boiling in decoctions of ''[[Triphala]]'' or [[Guduchi]] (''[[Tinospora cordifolia]]'') until liquid, then strained and dried into ''Shuddha Guggulu''. | |||
== Reference in Charak Samhita and its actions == | == Reference in Charak Samhita and its actions == | ||
| Line 423: | Line 425: | ||
== Botanical & Phytochemical Profile == | == Botanical & Phytochemical Profile == | ||
''Commiphora wightii'' is a slow-growing, thorny shrub or small tree native to arid regions of | ''Commiphora wightii'' is a slow-growing, thorny shrub or small tree native to arid regions of India (primarily Rajasthan and Gujarat), Pakistan, and parts of North Africa. The oleo-gum-resin is harvested via incision in the bark, yielding a yellow-brown balsam that hardens upon exposure to air. | ||
The chemical constitution of raw Guggulu comprises resin (ca. 61%), gum (ca. 29.3%), volatile oils (0.4–1.45%), and water-insoluble matter. Standardized extracts, often termed ''Gugulipid'', concentrate the active ketonic steroid fraction. | The chemical constitution of raw Guggulu comprises resin (ca. 61%), gum (ca. 29.3%), volatile oils (0.4–1.45%), and water-insoluble matter. Standardized extracts, often termed ''Gugulipid'', concentrate the active ketonic steroid fraction. | ||
| Line 435: | Line 437: | ||
| '''Phytosterols / Ketosteroids''' || ''E''-guggulsterone, ''Z''-guggulsterone, Guggulsterol I–V || Primary active markers; [[Farnesoid X receptor|FXR]] antagonism, hypolipidemic, thyroid activation. | | '''Phytosterols / Ketosteroids''' || ''E''-guggulsterone, ''Z''-guggulsterone, Guggulsterol I–V || Primary active markers; [[Farnesoid X receptor|FXR]] antagonism, hypolipidemic, thyroid activation. | ||
|- | |- | ||
| '''Monoterpenes & Sesquiterpenes''' || | | '''Monoterpenes & Sesquiterpenes''' || Myrcene, limonene, eugenol, caryophyllene || Constitute essential oil; contribute to antimicrobial and anti-inflammatory activity. | ||
|- | |- | ||
| '''Diterpenes''' || | | '''Diterpenes''' || Mukulol, cembranoids, allylcembrol || Cytotoxic and microbial inhibitory properties. | ||
|- | |- | ||
| '''Lignans & Ferulates''' || | | '''Lignans & Ferulates''' || Guggullignans, long-chain aliphatic tetrol ferulates || Antioxidant activity and free-radical scavenging capacity. | ||
|} | |} | ||
| Line 445: | Line 447: | ||
=== Hypolipidemic & Anti-Atherosclerotic Activity === | === Hypolipidemic & Anti-Atherosclerotic Activity === | ||
The hypolipidemic capacity of Guggulu is attributed to ''E''- and ''Z''-guggulsterones acting as competitive antagonists at the | The hypolipidemic capacity of Guggulu is attributed to ''E''- and ''Z''-guggulsterones acting as competitive antagonists at the Farnesoid X receptor (FXR), a nuclear receptor that regulates bile acid and cholesterol homeostasis.<ref name="Urizar2002">{{cite journal | last1 = Urizar | first1 = N. L. | last2 = Liverman | first2 = A. B. | last3 = Dodds | first3 = D. T. | last4 = Silva | first4 = F. V. | last5 = Ordentlich | first5 = P. | last6 = Yan | first6 = Y. | last7 = Gonzalez | first7 = F. J. | last8 = Heyman | first8 = R. A. | last9 = Mangelsdorf | first9 = D. J. | last10 = Moore | first10 = D. D. | year = 2002 | title = A natural product that lowers cholesterol as an antagonist ligand for FXR | journal = [[Science]] | volume = 296 | issue = 5573 | pages = 1703–1706 | doi = 10.1126/science.1072891 | pmid = 11988537}}</ref><ref name="Wu2002">{{cite journal | last1 = Wu | first1 = J. | last2 = Xia | first2 = C. | last3 = Meier | first3 = J. | last4 = Li | first4 = S. | last5 = Hu | first5 = X. | last6 = Lala | first6 = D. S. | year = 2002 | title = The hypolipidemic natural product guggulsterone acts as an antagonist of the bile acid receptor | journal = [[Molecular Endocrinology]] | volume = 16 | issue = 7 | pages = 1590–1597 | doi = 10.1210/mend.16.7.0894 | pmid = 12089353}}</ref> By blocking FXR activation, guggulsterone enhances hepatic bile salt export and upregulates hepatic LDL receptor expression, increasing cellular clearance of low-density lipoprotein (LDL). | ||
Clinical trials conducted in India demonstrated significant reductions in total serum cholesterol, triglycerides, and LDL-C, accompanied by increases or stabilization of | Clinical trials conducted in India demonstrated significant reductions in total serum cholesterol, triglycerides, and LDL-C, accompanied by increases or stabilization of high-density lipoprotein (HDL-C).<ref name="Nityanand1989">{{cite journal | last1 = Nityanand | first1 = S. | last2 = Srivastava | first2 = J. S. | last3 = Asthana | first3 = O. P. | year = 1989 | title = Clinical trials with guggulipid—a new hypolipidemic agent | journal = Journal of the Association of Physicians of India | volume = 37 | issue = 5 | pages = 323–328}}</ref> Additionally, guggulsterone exhibits lipid peroxide-scavenging properties, preventing the oxidative modification of LDL cholesterol—a crucial step in atherogenesis.<ref name="Deng2007">{{cite journal | last1 = Deng | first1 = R. | year = 2007 | title = Therapeutic effects of guggul and its constituent guggulsterone: cardiovascular benefits | journal = [[Cardiovascular Drug Reviews]] | volume = 25 | issue = 4 | pages = 375–390 | doi = 10.1111/j.1527-3466.2007.00023.x | pmid = 18078436}}</ref> | ||
=== Anti-Inflammatory & Anti-Arthritic Efficacy === | === Anti-Inflammatory & Anti-Arthritic Efficacy === | ||
Guggulsterone suppresses activation of the | Guggulsterone suppresses activation of the nuclear factor-kappa B (NF-κB) signaling pathway by downregulating IκB kinase (IKK), leading to suppression of downstream inflammatory mediators including cyclooxygenase-2 (COX-2), TNF-α, and interleukin-1 beta (IL-1β).<ref name="Shishodia2008">{{cite journal | last1 = Shishodia | first1 = S. | last2 = Harikumar | first2 = K. B. | last3 = Dass | first3 = S. | last4 = Ramawat | first4 = K. G. | last5 = Aggarwal | first5 = B. B. | year = 2008 | title = The guggul for chronic diseases: ancient medicine, modern targets | journal = Advances in Experimental Medicine and Biology | volume = 603 | pages = 308–321 | doi = 10.1007/978-0-387-75681-3_28 | pmid = 17966570}}</ref> This molecular cascade validates the traditional use of Guggulu preparations in treating inflammatory arthropathies such as osteoarthritis and rheumatoid arthritis (''Amavata''). | ||
=== Metabolic Regulation & Thyroid Stimulation === | === Metabolic Regulation & Thyroid Stimulation === | ||
In animal models, administration of Guggulu extract enhanced thyroid function by increasing the activity of | In animal models, administration of Guggulu extract enhanced thyroid function by increasing the activity of thyroid peroxidase and protease, thereby facilitating the peripheral conversion of thyroxine ($T_4$) into the active metabolic hormone triiodothyronine ($T_3$).<ref name="Panda1999">{{cite journal | last1 = Panda | first1 = S. | last2 = Kar | first2 = A. | year = 1999 | title = Gugulu (Commiphora mukul) induces triiodothyronine production: possible involvement of lipid peroxidation | journal = [[Life Sciences]] | volume = 65 | issue = 12 | pages = PL137–PL141 | doi = 10.1016/s0024-3205(99)00369-0 | pmid = 10503949}}</ref> This thyroid stimulation increases basal metabolic rate (BMR) and heat production, providing a mechanical explanation for its anti-obesity (''Sthoulyahara'') effects. | ||
=== Dermatological & Anti-Acne Actions === | === Dermatological & Anti-Acne Actions === | ||
Guggulsterones exhibit potent anti-seborrheic and antibacterial effects. A randomized comparative clinical trial demonstrated that oral administration of standardized guggulipid (25 mg guggulsterone twice daily) was as effective as oral | Guggulsterones exhibit potent anti-seborrheic and antibacterial effects. A randomized comparative clinical trial demonstrated that oral administration of standardized guggulipid (25 mg guggulsterone twice daily) was as effective as oral tetracycline (500 mg twice daily) in reducing inflammatory lesions in patients with severe nodulocystic acne vulgaris.<ref name="Thappa1994">{{cite journal | last1 = Thappa | first1 = D. M. | last2 = Dogra | first2 = J. | year = 1994 | title = Nodulocystic acne: oral guggulipid versus tetracycline | journal = The Journal of Dermatology | volume = 21 | issue = 10 | pages = 729–731 | doi = 10.1111/j.1346-8138.1994.tb03277.x | pmid = 7798435}}</ref> Notably, patients with oily skin responded significantly better to guggulipid therapy. | ||
== Posology & Common Ayurvedic Formulations == | == Posology & Common Ayurvedic Formulations == | ||
| Line 465: | Line 467: | ||
=== Classical Formulations === | === Classical Formulations === | ||
* '''Yograj Guggulu:''' Formulated for Vata disorders, chronic joint pain, and neuro-musculoskeletal stiffness. | * '''Yograj Guggulu:''' Formulated for Vata disorders, chronic joint pain, and neuro-musculoskeletal stiffness. | ||
* '''Kaishore Guggulu:''' Indicated for inflammatory joint disease, | * '''Kaishore Guggulu:''' Indicated for inflammatory joint disease, gout (''Vatarakta''), skin disorders, and blood purification. | ||
* ''' | * '''Kanchanar Guggulu:''' Used for lymphatic enlargements, thyroid nodules, cysts, and glandular swellings. | ||
* '''Triphala Guggulu:''' Target formulation for obesity, chronic inflammatory sinus conditions, and sluggish digestion. | * '''Triphala Guggulu:''' Target formulation for obesity, chronic inflammatory sinus conditions, and sluggish digestion. | ||
* '''Punarnavadi Guggulu:''' Indicated for edema, fluid retention, hyperuricemia, and renal stiffness. | * '''Punarnavadi Guggulu:''' Indicated for edema, fluid retention, hyperuricemia, and renal stiffness. | ||
| Line 472: | Line 474: | ||
== Safety, Toxicology & Contraindications == | == Safety, Toxicology & Contraindications == | ||
=== Adverse Reactions === | === Adverse Reactions === | ||
While purified Guggulu is generally well tolerated, reported adverse effects include mild | While purified Guggulu is generally well tolerated, reported adverse effects include mild gastrointestinal distress (nausea, diarrhea, eructation), skin rash/dermatitis, and transient elevations in liver enzymes at high dosages. | ||
=== Drug Interactions === | === Drug Interactions === | ||
* ''' | * '''CYP3A4 Inducers:''' Guggulsterones can induce CYP3A4 enzymes, potentially accelerating the hepatic metabolism and reducing the serum concentrations of drugs such as diltiazem, ketoconazole, or oral contraceptives. | ||
* ''' | * '''Anticoagulants & Antiplatelets:''' Concomitant administration with aspirin, warfarin, or clopidogrel may increase bleeding risk due to antiplatelet activity. | ||
* '''Thyroid Hormones:''' May potentiate the action of exogenous thyroid medications (e.g., | * '''Thyroid Hormones:''' May potentiate the action of exogenous thyroid medications (e.g., levothyroxine). | ||
=== Contraindications === | === Contraindications === | ||
* '''Pregnancy & Lactation:''' Emmenagogue and uterine-stimulating properties pose a potential risk of abortion. | * '''Pregnancy & Lactation:''' Emmenagogue and uterine-stimulating properties pose a potential risk of abortion. | ||
* '''Bleeding Disorders:''' Contraindicated in patients with active peptic ulceration, | * '''Bleeding Disorders:''' Contraindicated in patients with active peptic ulceration, thrombocytopenia, or scheduled for surgery. | ||
* '''Hormone-Sensitive Cancers:''' Due to weak affinity for | * '''Hormone-Sensitive Cancers:''' Due to weak affinity for estrogen receptors and androgen receptors, caution is warranted in breast, ovarian, or prostate malignancies. | ||
== References == | == References == | ||
| Line 490: | Line 492: | ||
[https://cb.imsc.res.in/imppat/phytochemical-detailedpage/IMPHY008908 IMPPAT database] | [https://cb.imsc.res.in/imppat/phytochemical-detailedpage/IMPHY008908 IMPPAT database] | ||
[[Category: Database of herbs and minerals | Herbs]] | [[index.php?title=Category:Database of herbs and minerals| Herbs]] | ||